![]() Akero Therapeutics Akero Therapeutics develops medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. | ||
Founding Date | Founding Date 2013 | Founding Date 2017 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Seattle, US HQ Seattle, US | Locations San Francisco, US HQ Cambridge, US South San Francisco, US |
Employees | Employees 254% increase | Employees 1363% increase |
Funding | ||
Total funding raised | Total funding raised $ 2.7m | Total funding raised $ 135m |

Akero Therapeutics develops medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.
View company